問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Principal Investigator
楊志新
下載
2018-04-15 - 2025-04-30
Condition/Disease
Test Drug
Participate Sites1Sites
Terminated1Sites
2019-11-01 - 2029-03-31
Participate Sites3Sites
Recruiting3Sites
2020-04-01 - 2028-12-31
Participate Sites6Sites
Recruiting6Sites
2020-05-01 - 2024-04-15
Participate Sites9Sites
Terminated9Sites
2021-08-01 - 2024-11-01
Participate Sites5Sites
Recruiting4Sites
2018-06-08 - 2021-01-31
Terminated6Sites
2022-05-01 - 2026-01-11
Participate Sites11Sites
Recruiting11Sites
2022-09-03 - 2027-08-09
Recruiting9Sites
2023-03-01 - 2029-04-01
Participate Sites4Sites
Not yet recruiting3Sites
Recruiting1Sites
2025-05-01 - 2030-04-30
Extensive-stage small cell lung cancer (ES-SCLC)
sacituzumab govitecan
全部
